About therapeuticsmd - TXMD
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
TXMD At a Glance
TherapeuticsMD, Inc.
951 Yamato Road
Boca Raton, Florida 33431
| Phone | 1-561-961-1900 | Revenue | 3.02M | |
| Industry | Pharmaceuticals: Major | Net Income | -569,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 71.607% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1 | |
| View SEC Filings |
TXMD Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.24 |
| Price to Book Ratio | 0.702 |
| Price to Cash Flow Ratio | 7.78 |
| Enterprise Value to EBITDA | -5.783 |
| Enterprise Value to Sales | 5.781 |
| Total Debt to Enterprise Value | 0.349 |
TXMD Efficiency
| Revenue/Employee | 3,022,000.00 |
| Income Per Employee | -569,000.00 |
| Receivables Turnover | 0.857 |
| Total Asset Turnover | 0.079 |
TXMD Liquidity
| Current Ratio | 2.531 |
| Quick Ratio | 2.531 |
| Cash Ratio | 1.564 |
TXMD Profitability
| Gross Margin | 60.523 |
| Operating Margin | -139.444 |
| Pretax Margin | -21.608 |
| Net Margin | -18.829 |
| Return on Assets | -1.708 |
| Return on Equity | -2.408 |
| Return on Total Capital | -1.98 |
| Return on Invested Capital | -2.012 |
TXMD Capital Structure
| Total Debt to Total Equity | 22.686 |
| Total Debt to Total Capital | 18.491 |
| Total Debt to Total Assets | 16.191 |
| Long-Term Debt to Equity | 19.058 |
| Long-Term Debt to Total Capital | 15.534 |